{"id":"NCT02829775","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies","officialTitle":"Extension Protocol for Patients With Chronic Myelogenous Leukemia, Malignant Melanoma or Renal Cell Carcinoma That Have Responded to Treatment With Pegylated-Interferon α-2a or Roferon-A® in Prior Clinical Studies","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2004-01","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2016-07-12","resultsPosted":"2016-11-17","lastUpdate":"2017-01-09"},"enrollment":9,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Myelogenous Leukemia","Malignant Melanoma","Renal Cell Carcinoma"],"interventions":[{"type":"DRUG","name":"Pegylated Interferon Alfa-2a","otherNames":["Pegasys"]},{"type":"DRUG","name":"Recombinant Interferon Alfa 2a","otherNames":["Roferon-A"]}],"arms":[{"label":"Interferon Alfa-2A in Cancer Participants","type":"EXPERIMENTAL"}],"summary":"This open label extension study will give an opportunity to the participants that have responded to the treatment with Pegylated-Interferon Alfa-2a (Pegasys) or Recombinant Interferon Alfa-2a (Roferon-A®) in prior clinical studies NO15753 (NCT00003542) for Renal Cell Carcinoma (RCC), NO15764 (NCT number not available) and NO16006 (NCT02736721) for Chronic Myelogenous Leukemia (CML), and NO16007 (NCT number not available) for Malignant Melanoma (MM).","primaryOutcome":{"measure":"Number of Participants With Serious Adverse Events (SAEs)","timeFrame":"Baseline up to approximately 3 years","effectByArm":[{"arm":"Interferon Alfa-2A in Cancer Participants","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":8,"countries":["Bulgaria","Canada","India","Russia","Slovakia","South Africa","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":9},"commonTop":[]}}